To investigate whether VPS34-IN-1 eliminates liver CSCs via the inhibition of autophagy, we treated HCC cells with VPS34-IN-1 plus rapamycin, an mTOR signaling inhibitor, to induce autophagy. This evidence concerns the gene MTOR and hepatocellular carcinoma.